The device section of the neurotech industry showed itself to be in relatively good health at May’s Neurotech Investing and Partnering Conference in San Francisco, but investment in these complex technologies is not always easy to come by.
Overall revenues in neurotech declined by 2 percent in 2012, but device revenues increased by 9 percent, and some conference attendees argued that the headline numbers flattered
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?